Drug recall · February 7, 2018
Ultane (sevoflurane) recall
Why: Defective container: presence of a hole in the liners of the caps covering the product bottle, introducing possibility of leakage.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Ultane (sevoflurane), 250 mL, Inhalation Anesthetic, Rx only, Manufactured by: AbbVie Inc., North Chicago, IL 60064, USA. NDC 0074-4456-51
- Lots / codes
Lot #: 1088856, Exp 6/20
- Quantity
- 7,770 bottles
- Company
- AbbVie Inc., North Chicago, IL
- Distribution
- MS, OH
- Initiated
- January 22, 2018 · Voluntary: Firm initiated
- Classified
- February 9, 2018
- Reported
- February 7, 2018
- Ended
- September 13, 2018
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Sevoflurane
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.